Risk Factors for Major Adverse Cardiovascular Events in Patients Aged >= 50 Years with RA and >= 1 Additional Cardiovascular Risk Factor: Results from a Phase 3b/4 Randomized Safety Study of Tofacitinib vs TNF Inhibitors
ARTHRITIS & RHEUMATOLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要